Sponsor Pipeline

Hangzhou Weben Pharma Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07014449 Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia AML (Acute Myelogenous Leukemia Recruiting
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1)
Get alerts when Hangzhou Weben Pharma Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free